Company Search:
Advanced Search
Sponsored Links
Reprocell Inc Company Snapshot
Reprocell Inc operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reprocell Inc with three other pharmaceutical manufacturers in Asia: Nutraplus India Ltd of India (2017 sales of 914.19 million Indian Rupees [US$14.31 million] ), Ngl Fine Chem Ltd of India (1.00 billion Indian Rupees [US$15.67 million] ), and Natural Capsules Limited which is also based in India (536.43 million Indian Rupees [US$8.40 million] ).

Sales Analysis. During the year ended March of 2017, sales at Reprocell Inc were ¥1.26 billion (US$11.31 million). This is an increase of 18.0% versus 2016, when the company's sales were ¥1.07 billion. This was the fifth consecutive year of sales increases at Reprocell Inc (and since 2012, sales have increased a total of 297%). Sales of Research Support Business saw an increase of 20.7% in 2017, from ¥999.93 million to ¥1.21 billion. Not all segments of Reprocell Inc experienced an increase in sales in 2017: sales of Medical Business fell 23.3% to ¥50.95 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Reprocell Inc
  Stock Performance Chart for Reprocell Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 347.00
(Figures in Japanese Yen)
1 Week -6.2%   13 Weeks 10.5%  
4 Weeks -1.4%   52 Weeks -16.6%  
Reprocell Inc Key Data:
  Ticker: 4978 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 1,257,812,000
(Year Ending Jan 2018).
Employees: 60
  Currency: Japanese Yen Market Cap: 22,177,686,427
  Fiscal Yr Ends: March Shares Outstanding: 63,912,641
  Share Type: Common Closely Held Shares: 6,151,104
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.